Fulltext
The Full text is available in PDF.
International Journal of Cancer Management
The Official Journal of Cancer Research Center (CRC), Shahid Beheshti University of Medical Sciences
e-ISSN 2538-497X
p-ISSN 2538-4422
Evaluation of Copper, Zinc, Cu/Zn, and VEGF in Patients with AML in Iran
Authors
Zohreh Sanaat1,*, M Nouri2, B Hajipour1, R Dolatkhah1, I Asvadi1, J Vaez1, J Eivazi1, A Nikanfar1, A Esfahani1, SH Chavoshi1, H Biorani3
1Hematology and Oncology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran
2Department of Biochemistry, Tabriz University of Medical Sciences, Tabriz, Iran
3Department of Mathematic, Tabriz University, Tabriz, Iran
*Corresponding Author: Corresponding author: Zohreh Sanaat, Hematology and Oncology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran, Tel: +98-4113343811, E-mail: Email: [email protected]
Published online:Dec 30, 2011
Article type:Brief Report
Received:Feb 18, 2011
Accepted:Jul 12, 2011
How to Cite:Sanaat Z, Nouri M, Hajipour B, Dolatkhah R, Asvadi I, et al. Evaluation of Copper, Zinc, Cu/Zn, and VEGF in Patients with AML in Iran. Int J Cancer Manag. 2011;4(4):e80749. doi:
Abstract
Background: Copper and zinc are the elements with numerous physiological activities. Copper (Cu) has an important role in angiogenesis and acts by increasing Vascular Endothelial Growth Factor (VEGF). Serum levels of copper will be increased in cancer incidence, progression and recurrence. The aim of this study was to measure blood levels of copper, zinc, and the ratio of Cu /Zn, as well as VEGF levels before and after treatment of acute myeloid leukemia.
Methods: Thirty patients who were recently diagnosed with Acute Myeloblastic Leukemia (AML) in Shahid Ghazi Tabatabai oncology hospital enrolled in this clinical trial. On the first day, blood samples were taken for copper, zinc, and VEGF assay and flowcytometry. Treatment protocol was (7×3) regimen. Blood samples were collected for evaluation of copper, zinc, and VEGF. They were sent to Biochemistry Laboratory in medicine faculty for analysis.
Results: Amongst 30 AML patients, 14 (46.7%) were female and 16 (53.3%) were male. Patients of various ages ranged from 16 to 53 years, with a median age of 9.1±9.35 years. The mean serum level of copper, zinc, and mean Cu/Zn ratio before and after treatment showed significant difference (p<0.05) There was also significant difference between the mean VEGF level before and after treatment (p<0.05).
Conclusion: This study reveals that there is no significant relationship between copper, zinc serum levels, their ratio, and VEGF in AML patients. We hypothesize that increased serum copper is associated with increase of VEGF levels which can indicate the impact of copper in malignancies including AML.
Copyright
© 2011, Author(s). This open-access article is available under the Creative Commons Attribution 4.0 (CC BY 4.0) International License (https://creativecommons.org/licenses/by/4.0/), which allows for unrestricted use, distribution, and reproduction in any medium, provided that the original work is properly cited.
Similar Articles
30
Aug
2025
Effect of Serum Ferritin Level on the Response to Standard Chemotherapy in Acute Myeloid Leukemia Patients
Nasrin Namdari,
Ali Ghane-Shahmirzadi,
Sezaneh Haghpanah,
Maral Mokhtari
Namdari N, Ghane-Shahmirzadi A, Haghpanah S, Mokhtari M. Effect of Serum Ferritin Level on the Response to Standard Chemotherapy in Acute Myeloid Leukemia Patients. Shiraz E-Med J. 2025;26(11):e161086. doi: https://doi.org/10.5812/semj-161086
16
Aug
2025
The Effect of Intravenous Iron Therapy in Chemotherapy-Induced Anemia in Patients with Non-metastatic Breast Cancer
Nasrin Namdari,
Mahya Amini,
Zahra Ghazanfari,
Shirin Haghighat
Namdari N, Amini M, Ghazanfari Z, Haghighat S. The Effect of Intravenous Iron Therapy in Chemotherapy-Induced Anemia in Patients with Non-metastatic Breast Cancer. Shiraz E-Med J. 2026;26(10):e160759. doi: https://doi.org/10.5812/semj-160759
31
Aug
2017
The Effect of Orally-Administered Zinc in the Prevention of Chemotherapy-Induced Oral Mucositis in Patients with Acute Myeloid Leukemia
Narges Gholizadeh,
Masoumeh Mehdipour,
Seyyed Hadi Chavoshi,
Sirvan Kahani,
Maryam-Sadat Sadrzadeh-Afshar
Gholizadeh N, Mehdipour M, Chavoshi SH, Kahani S, Sadrzadeh-Afshar M. The Effect of Orally-Administered Zinc in the Prevention of Chemotherapy-Induced Oral Mucositis in Patients with Acute Myeloid Leukemia. Int J Cancer Manag. 2017;10(8):e9252. doi: https://doi.org/10.5812/ijcm.9252
28
Sep
2016
Factors that affecting survival of patients with acute myeloid leukemia
Alireza Akbarzadeh Baghban,
Hossein Hosseinifard,
Ahmad Reza Baghestani,
Saharnaz Ahmadi,
Mostafa Rezaei tavirani,
parviz Kokhaei
Akbarzadeh Baghban A, Hosseinifard H, Baghestani AR, Ahmadi S, Rezaei tavirani M, et al. Factors that affecting survival of patients with acute myeloid leukemia. koomesh. 2016;17(3):e151206. doi:
30
Sep
2009
Results of Chemotherapy with BFM-87 Protocol in Children with Acute Myeloid Leukemia at a Referral Center in the Southwest of Iran: Clinical Characteristics and Outcome
Mohammad Pedram,
AA Hiradfar
Pedram M, Hiradfar A. Results of Chemotherapy with BFM-87 Protocol in Children with Acute Myeloid Leukemia at a Referral Center in the Southwest of Iran: Clinical Characteristics and Outcome. Int J Cancer Manag. 2009;2(3):e80573. doi:
More by these authors
Cited by
- Scopus by DOI: 0
Last Update: 3 weeks ago
- Scopus by Title: 8
Last Update: 3 weeks ago
- Scopus by Title (Ref): 8
Last Update: 3 weeks ago
- CrossRef: 0
Last Update: 3 days ago
Comments
Number of Comments:0